Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

532 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The impact of the COVID-19 pandemic on Italian population-based cancer screening activities and test coverage: Results from national cross-sectional repeated surveys in 2020.
Giorgi Rossi P, Carrozzi G, Falini P, Sampaolo L, Gorini G, Zorzi M, Armaroli P, Senore C, Sassoli de Bianchi P, Masocco M, Zappa M, Battisti F, Mantellini P. Giorgi Rossi P, et al. Among authors: zorzi m. Elife. 2023 Feb 3;12:e81804. doi: 10.7554/eLife.81804. Elife. 2023. PMID: 36734526 Free PMC article.
Human papillomavirus testing and liquid-based cytology: results at recruitment from the new technologies for cervical cancer randomized controlled trial.
Ronco G, Segnan N, Giorgi-Rossi P, Zappa M, Casadei GP, Carozzi F, Dalla Palma P, Del Mistro A, Folicaldi S, Gillio-Tos A, Nardo G, Naldoni C, Schincaglia P, Zorzi M, Confortini M, Cuzick J; New Technologies for Cervical Cancer Working Group. Ronco G, et al. Among authors: zorzi m. J Natl Cancer Inst. 2006 Jun 7;98(11):765-74. doi: 10.1093/jnci/djj209. J Natl Cancer Inst. 2006. PMID: 16757701 Clinical Trial.
Audit system on Quality of breast cancer diagnosis and Treatment (QT): results from the survey on screen-detected lesions in Italy, 2003-2004.
Ponti A, Mano MP, Distante V, Taffurelli M, Naldoni C, Zangirolami F, Vettorazzi M, Zorzi M, Pagano G, Federici A, Baiocchi D, Bordon R, Tomatis M, Mantellini P, Cataliotti L, Rosselli del Turco M, Segnan N. Ponti A, et al. Among authors: zorzi m. Epidemiol Prev. 2006 Jan-Feb;30(1 Suppl 3):59-63. Epidemiol Prev. 2006. PMID: 16937847 Free article.
HPV triage for low grade (L-SIL) cytology is appropriate for women over 35 in mass cervical cancer screening using liquid based cytology.
Ronco G, Cuzick J, Segnan N, Brezzi S, Carozzi F, Folicaldi S, Dalla Palma P, Del Mistro A, Gillio-Tos A, Giubilato P, Naldoni C, Polla E, Iossa A, Zorzi M, Confortini M, Giorgi-Rossi P; NTCC working group. Ronco G, et al. Among authors: zorzi m. Eur J Cancer. 2007 Feb;43(3):476-80. doi: 10.1016/j.ejca.2006.11.013. Epub 2007 Jan 12. Eur J Cancer. 2007. PMID: 17223540
The impact of new technologies in cervical cancer screening: results of the recruitment phase of a large randomised controlled trial from a public health perspective.
Giorgi-Rossi P, Segnan N, Zappa M, Naldoni C, Zorzi M, Confortini M, Merito M, Cuzick J, Ronco G; NTCC Working Group. Giorgi-Rossi P, et al. Among authors: zorzi m. Int J Cancer. 2007 Dec 15;121(12):2729-34. doi: 10.1002/ijc.23055. Int J Cancer. 2007. PMID: 17724715 Free article. Clinical Trial.
The New Technologies for Cervical Cancer Screening randomised controlled trial. An overview of results during the first phase of recruitment.
Ronco G, Brezzi S, Carozzi F, Dalla Palma P, Giorgi-Rossi P, Minucci D, Naldoni C, Segnan N, Zappa M, Zorzi M, Cuzick J; NTCC study group. Ronco G, et al. Among authors: zorzi m. Gynecol Oncol. 2007 Oct;107(1 Suppl 1):S230-2. doi: 10.1016/j.ygyno.2007.07.021. Epub 2007 Sep 6. Gynecol Oncol. 2007. PMID: 17822751 Clinical Trial.
Screening for colorectal cancer in Italy: 2005 survey.
Zorzi M, Barca A, Falcini F, Grazzini G, Pizzuti R, Ravaioli A, Sassoli de Bianchi P, Senore C, Sigillito A, Vettorazzi M, Visioli C. Zorzi M, et al. Epidemiol Prev. 2007 Mar-Jun;31(2-3 Suppl 2):49-60. Epidemiol Prev. 2007. PMID: 17824362 Free article.
Results at recruitment from a randomized controlled trial comparing human papillomavirus testing alone with conventional cytology as the primary cervical cancer screening test.
Ronco G, Giorgi-Rossi P, Carozzi F, Confortini M, Dalla Palma P, Del Mistro A, Gillio-Tos A, Minucci D, Naldoni C, Rizzolo R, Schincaglia P, Volante R, Zappa M, Zorzi M, Cuzick J, Segnan N; New Technologies for Cervical Cancer Screening Working Group. Ronco G, et al. Among authors: zorzi m. J Natl Cancer Inst. 2008 Apr 2;100(7):492-501. doi: 10.1093/jnci/djn065. Epub 2008 Mar 25. J Natl Cancer Inst. 2008. PMID: 18364502 Clinical Trial.
532 results